Skip to the answer

Levocarnitine

Levocarnitine is a naturally occurring substance used to treat primary and secondary carnitine deficiency, including in people with end stage renal disease who are on dialysis.

Brand names CarnitorCarnitor SF
Drug class Carnitine Analog
Rx Forms 3
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026 Content updated Oct 2, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 11 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

How we combine label and product data →
✓No current FDA shortage listed · checked Oct 3, 2026 🚨Recall on record
Levocarnitine at a glance The quick version — the full detail is in the Patient Information Guide below.
Dr. Brian Staiger, PharmD, BCPS
The Pharmacist’s Take By · Clinical pharmacist · Written

Levocarnitine replaces carnitine, the natural substance cells use to carry fats into their mitochondria (energy factories), and it is a specialist medicine for primary carnitine deficiency, for inherited metabolic disorders that cause a secondary deficiency and, by injection, for people on dialysis for end stage renal disease, on the market since about 1985 and available as a generic. It is generally well tolerated; brief nausea, stomach upset, diarrhea at higher doses or a body odor are what people notice. Watch for a serious allergic reaction (wheezing, throat swelling, trouble breathing), reported mostly in people on dialysis and sometimes within minutes of an IV dose, and report new or worsening seizures.

Clinical pearls

  • If you take warfarin, have your INR (a clotting test) checked after starting levocarnitine or changing the dose, since it can rise.
  • The oral solution is for drinking only and must never be injected into a vein or IV line.
  • On dialysis, the injection is given after each session, so tell the nurse right away about any breathing or throat change.
  • Your prescriber sets and adjusts the dose from blood test results, so keep lab appointments even when you feel well.
How we write & review this content — our editorial policy →
How you get itPrescription only
Comes asOral solution, Injection, Tablet
Earliest FDA record1985
Companies listing it with the FDA24
FDA label last updatedOct 30, 2024
FDA’s strongest warning (boxed)None on the label

Patient information guide — a plain-language walkthrough of Levocarnitine, written from its FDA label.

What Levocarnitine is used for

▾

Levocarnitine is used for several types of carnitine deficiency, depending on the product.

  • Primary systemic carnitine deficiency: Carnitor tablets and oral solution, Carnitor SF oral solution, and levocarnitine oral solution and tablets.
  • Secondary carnitine deficiency from an inborn error of metabolism: oral products (Carnitor, Carnitor SF, levocarnitine) and levocarnitine/Carnitor injection.
  • Prevention and treatment of carnitine deficiency in end stage renal disease patients on dialysis: levocarnitine/Carnitor intravenous injection.

How Levocarnitine works

▾

Levocarnitine is a natural substance needed for energy production. It helps carry long-chain fatty acids into mitochondria, the cell's energy factories, where they are burned for fuel. Heart and skeletal muscle depend heavily on this process.

In some inborn metabolic disorders, toxic acid compounds build up. Levocarnitine binds them to form acylcarnitine, which the body quickly removes in urine.

Levocarnitine dosage

▾

Dosing depends on the product and your condition, so follow your prescriber and label.

  • Carnitor and levocarnitine tablets are taken by mouth, usually two or three times a day in adults, or in divided doses for children.
  • Carnitor, Carnitor SF and levocarnitine oral solution are taken by mouth only. Treatment usually starts low and is increased slowly.
  • Carnitor and levocarnitine injection is given into a vein by a healthcare team. In dialysis patients, it is given after each session.

Regular blood tests and checks of carnitine levels guide adjustments.

Dosing details from the FDA-approved label

From the Levocarnitine prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.

  • Adults (oral tablets)
    • 990 mg two or three times a day using the 330 mg tablets, depending on clinical response
  • Infants and children (oral tablets)
    • Between 50 and 100 mg/kg/day in divided doses
    • Dosage should begin at 50 mg/kg/day
    • Exact dosage will depend on clinical response
    • Maximum: 3 g/day
    • Weight-based dosing
  • Adults (oral solution)
    • 1 to 3 g/day for a 50 kg subject, equivalent to 10 to 30 mL/day
    • Dosage should start at 1 g/day (10 mL/day) and be increased slowly while assessing tolerance and therapeutic response
    • Higher doses only with caution; doses spaced evenly throughout the day (every three or four hours), preferably during or following meals, consumed slowly
  • Infants and children (oral solution)
    • 50 to 100 mg/kg/day, equivalent to 0.5 mL/kg/day
    • Start at 50 mg/kg/day and increase slowly while assessing tolerance and therapeutic response
    • Maximum: 3 g/day (30 mL/day)
    • Higher doses only with caution; doses spaced evenly throughout the day (every three or four hours), preferably during or following meals
  • Metabolic disorders (intravenous injection)
    • 50 mg/kg given as a slow 2-3 minute bolus injection or by infusion
    • Often a loading dose is given in severe metabolic crisis, followed by an equivalent dose over the following 24 hours, administered q3h or q4h, and never less than q6h
    • Subsequent daily doses in the range of 50 mg/kg or as therapy may require
    • Maximum: The highest dose administered has been 300 mg/kg
    • Obtain plasma carnitine concentration before beginning parenteral therapy; weekly and monthly monitoring recommended
  • ESRD patients on hemodialysis (intravenous injection)
    • Starting dose 10-20 mg/kg dry body weight as a slow 2-3 minute bolus injection into the venous return line after each dialysis session
    • Adjust by trough (pre-dialysis) levocarnitine concentrations; downward adjustments (e.g. to 5 mg/kg after dialysis) may be made as early as the third or fourth week
Read the label’s full dosing text

DOSAGE AND ADMINISTRATION CARNITOR ® (levocarnitine) Tablets. Adults: The recommended oral dosage for adults is 990 mg two or three times a day using the 330 mg tablets, depending on clinical response. Infants and children: The recommended oral dosage for infants and children is between 50 and 100 mg/kg/day in divided doses, with a maximum of 3 g/day. Dosage should begin at 50 mg/kg/day. The exact dosage will depend on clinical response. Monitoring should include periodic blood chemistries, vital signs, plasma carnitine concentrations and overall clinical condition. CARNITOR ® (levocarnitine) Oral Solution and CARNITOR ® SF (levocarnitine) Sugar-Free Oral Solution. For oral use only. Not for parenteral use. Adults: The recommended dosage of levocarnitine is 1 to 3 g/day for a 50 kg subject, which is equivalent to 10 to 30 mL/day of CARNITOR ® (levocarnitine) Oral Solution or CARNITOR ® SF (levocarnitine) Sugar-Free Oral Solution. Higher doses should be administered only with caution and only where clinical and biochemical considerations make it seem likely that higher doses will be of benefit. Dosage should start at 1 g/day, (10 mL/day), and be increased slowly while assessing tolerance and therapeutic response. Monitoring should include periodic blood chemistries, vital signs, plasma carnitine concentrations, and overall clinical condition. Infants and children: The recommended dosage of levocarnitine is 50 to 100 mg/kg/day which is equivalent to 0.5 mL/kg/day CARNITOR ® (levocarnitine) Oral Solution or CARNITOR ® SF (levocarnitine) Sugar-Free Oral Solution. Higher doses should be administered only with caution and only where clinical and biochemical considerations make it seem likely that higher doses will be of benefit. Dosage should start at 50 mg/kg/day, and be increased slowly to a maximum of 3 g/day (30 mL/day) while assessing tolerance and therapeutic response. Monitoring should include periodic blood chemistries, vital signs, plasma carnitine concentrations, and overall clinical condition. CARNITOR ® (levocarnitine) Oral Solution or CARNITOR ® SF (levocarnitine) Sugar-Free Oral Solution may be consumed alone or dissolved in drink or other liquid food. Doses should be spaced evenly throughout the day (every three or four hours) preferably during or following meals and should be consumed slowly in order to maximize tolerance.

Read the full Dosage and Administration section on DailyMed →

Levocarnitine side effects

▾

Common side effects

  • Nausea and vomiting (usually brief)
  • Body odor
  • Stomach irritation (gastritis)
  • Diarrhea, especially with large doses
  • Injection site reaction (IV use in dialysis patients)
  • Headache
  • Dizziness

When to get medical help

  • Get emergency help for signs of a severe allergic reaction: trouble breathing, wheezing, throat or voice swelling.
  • Tell your doctor right away if you have a seizure, or if seizures become more frequent or severe.
  • Report any reaction that appears within minutes of an IV dose to your care team immediately.

Most side effects are mild.

  • Nausea and vomiting, usually brief
  • Body odor
  • Gastritis (stomach irritation)
  • Diarrhea with large doses
  • In dialysis trials: injection site reactions, headache, dizziness, and others also occurred, though many were also seen with placebo

Seek help right away for signs of a severe allergic reaction or for seizures.

Levocarnitine warnings and precautions

▾

Serious allergic reactions (anaphylaxis, throat swelling, bronchospasm) have been reported, mostly in dialysis patients with end stage renal disease. Some happened within minutes of an IV dose. Treatment is stopped if a severe reaction occurs.

Seizures have been reported with oral and IV use. People with existing seizures have had more frequent or severe seizures.

Levocarnitine interactions

▾

One key interaction is noted.

  • Warfarin: INR (a clotting test) may rise, so it should be checked after starting levocarnitine or changing the dose.

Interactions listed in the FDA-approved label

From the Levocarnitine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Warfarin: Reports of INR increase with the use of warfarin have been observed. Monitor INR levels in patients on warfarin therapy after the initiation of treatment with levocarnitine or after dose adjustments.
Read the label’s full interactions text

Drug Interactions Reports of INR increase with the use of warfarin have been observed. It is recommended that INR levels be monitored in patients on warfarin therapy after the initiation of treatment with levocarnitine or after dose adjustments.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Check Levocarnitine against a supplement or herb →

Before taking Levocarnitine

▾
  • Tell your prescriber if you take warfarin.
  • Tell your prescriber if you have seizures.
  • Tell your prescriber if you have had a past allergic reaction to levocarnitine.
  • If you have end stage renal disease on dialysis, ask what allergy signs to watch for.
  • No contraindications are known.

Levocarnitine overdose

▾

No toxicity from levocarnitine overdose has been reported. Large doses may cause diarrhea. Levocarnitine is easily removed from the blood by dialysis.

What Levocarnitine does in the body

▾

Levocarnitine helps move fatty acids into cells for energy and helps clear toxic acid compounds in certain metabolic disorders. In dialysis patients, it raises low blood carnitine levels. Its effect on symptoms and clinical outcomes in this group has not been determined.

How your body processes Levocarnitine

▾

Only a small share of an oral dose is absorbed: about 15% for both tablets and oral solution. Blood levels peak around 3.3 hours after oral dosing. The tablets and oral solution were found bioequivalent in a study. It does not bind to plasma proteins, and about 76% of an IV dose leaves in urine within 24 hours. Its terminal half-life is about 17 hours.

How to store Levocarnitine

▾

Store in original packaging: content hygroscopic. Store at 20°C to 25°C (68°F to 77°F). Avoid excessive heat and protect from freezing.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

Levocarnitine: pharmacist answers to common questions

Quick, plain-English answers to the questions patients ask most about Levocarnitine — the kind of thing our pharmacy team would talk through with you at the counter.

What is levocarnitine for?

▾
It replaces carnitine when your body doesn't have enough. That can be from primary carnitine deficiency, an inherited metabolic disorder, or, with the injection, dialysis for end stage renal disease. Carnitine helps your cells turn fat into energy.

How do I take it?

▾
Tablets and oral solution are taken by mouth, usually a couple of times a day. The oral solution is never to be injected. The injection is given into a vein by your care team. Your prescriber will adjust the amount based on your blood tests, so follow your label closely.

What side effects should I expect?

▾
Some people have nausea, vomiting, body odor, or an upset stomach. Large doses may cause diarrhea. These are often temporary, but tell your pharmacist or doctor if they bother you.

When should I get urgent help?

▾
Call for emergency help if you have trouble breathing, wheezing, or swelling of your throat after a dose. Also call your doctor if you have a seizure. Seizures have been reported, and they can get worse in people who already have them.

Does it interact with other medicines?

▾
The label notes warfarin. Levocarnitine may raise your INR, so your clotting tests should be checked after you start it or change the dose. Tell us about every medicine you take.

Do I need blood tests?

▾
Yes. Your prescriber will check things like blood chemistries and carnitine levels, and review your overall condition. This helps them set the right dose for you.

Is Levocarnitine available over the counter?

▾
No. Levocarnitine is a prescription medicine: every Levocarnitine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was Levocarnitine first available?

▾
The earliest FDA record we hold for Levocarnitine is from 1985: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when Levocarnitine was first used.

Who makes Levocarnitine?

▾
24 companies list Levocarnitine products in the FDA's NDC Directory, including Leadiant Biosciences, Inc., American Regent, Inc., ANI Pharmaceuticals, Inc.. That count includes repackagers and distributors as well as manufacturers, so fewer companies actually make it; the label on your bottle names the one that supplied yours.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

More about Levocarnitine on HelloPharmacist

🌿Drug & Supplement CheckerLevocarnitine vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Levocarnitine NDCs & costs 🅰️Browse Drugs A–ZLook up any medication
Detailed data & references for Levocarnitine Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here. Each section below opens on a tap.

Levocarnitine forms and strengths (how it comes)

Levocarnitine is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Oral solution

By mouth
Brands Carnitor Carnitor SF
How this form is used
What it may be used for
  • Carnitor, Carnitor SF and Levocarnitine oral solution are used for primary systemic carnitine deficiency.
  • Carnitor, Carnitor SF and Levocarnitine oral solution are also used for secondary carnitine deficiency from an inborn error of metabolism.
Important instructions
  • Carnitor, Carnitor SF and Levocarnitine oral solution are for oral use only, not for injection.
  • Carnitor, Carnitor SF and Levocarnitine oral solution are started at a lower amount and increased slowly while tolerance and response are checked.
Available strengths 1 strength
1 g/10 mL
15 FDA-listed product records ⓘ

Injection

Into a vein
Brands Carnitor
How this form is used
What it may be used for
  • Carnitor and levocarnitine injection are used for acute and chronic treatment of secondary carnitine deficiency from an inborn error of metabolism.
  • Carnitor and levocarnitine injection are used to prevent and treat carnitine deficiency in people with end stage renal disease on dialysis.
Important instructions
  • Carnitor and levocarnitine injection are given into a vein, either as a slow injection over a few minutes or as an infusion.
  • For people on hemodialysis, Carnitor and levocarnitine injection are given after each dialysis session.
  • Carnitor and levocarnitine injection treatment includes blood carnitine level monitoring.
Available strengths 2 strengths
200 mg/mL 1 g/5 mL
9 FDA-listed product records ⓘ

Tablet

By mouth
Brands Carnitor
How this form is used
What it may be used for
  • Carnitor and Levocarnitine tablets are used for primary systemic carnitine deficiency.
  • Carnitor and Levocarnitine tablets are also used for secondary carnitine deficiency from an inborn error of metabolism.
Important instructions
  • Carnitor and Levocarnitine tablets are taken by mouth, usually two or three times a day in adults.
  • Carnitor and Levocarnitine tablets treatment includes periodic blood tests and checks of carnitine levels.
Available strengths 1 strength
330 mg
8 FDA-listed product records ⓘ

Levocarnitine on the U.S. market: products, makers and brands

How Levocarnitine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

24 companies list 45 Levocarnitine product records with the FDA, mostly as oral solution, injection, tablet; the earliest marketing or approval year on record is 1985. Brand names on the directory include Carnitor, Carnitor SF; the rest are generics.

3
Dose forms ⓘ
24
Labelers (makers, repackagers, distributors)
3
Brand names
45
FDA-listed product records ⓘ
1985
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (13) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Leadiant Biosciences, Inc.24%
American Regent, Inc.9%
ANI Pharmaceuticals, Inc.9%
Rising Pharma Holdings, Inc.7%
Akorn4%
Willow Birch Pharma, LLC4%
Other makers42%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Levocarnitine is used (Medicaid data)

A general measure of how commonly Levocarnitine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Levocarnitine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

141,917
Medicaid prescriptions filled (Q1–Q4 2025)
$15.4M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Levocarnitine prescribed? Of the 1,601 medications we measure, Levocarnitine ranks #449 by Medicaid prescriptions — more than 72% of them.

Where Levocarnitine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #449 of 1,601
#444 Somatropin 142,879 Rx #445 Indomethacin 142,731 Rx #446 Lovastatin 141,955 Rx #447 Regadenoson 141,955 Rx #448 Dexlansoprazole 141,938 Rx #449 Levocarnitine 141,917 Rx #450 Acetazolamide 141,794 Rx #451 Letrozole 140,810 Rx #452 Cenobamate 139,992 Rx #453 Empagliflozin / Metfor... 139,145 Rx #454 Ramelteon 138,690 Rx

Utilization by Levocarnitine product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 100 mg/mL oral solution is the most-dispensed Levocarnitine product — about 52% of these Medicaid prescriptions.

levocarnitine 100 MG/ML Oral Solution Most dispensed

73,125 Medicaid prescriptions (Q1–Q4 2025) 52% of Levocarnitine prescriptions shown $4.6M gross reimbursement (before rebates) ≈ $63 per prescription (gross)

Summed across the 6 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 315134

levocarnitine 330 MG Oral Tablet

40,352 Medicaid prescriptions (Q1–Q4 2025) 28% of Levocarnitine prescriptions shown $3.5M gross reimbursement (before rebates) ≈ $86 per prescription (gross)

Summed across the 3 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197448

5 ML levocarnitine 200 MG/ML Injection

25,801 Medicaid prescriptions (Q1–Q4 2025) 18% of Levocarnitine prescriptions shown $7.2M gross reimbursement (before rebates) ≈ $278 per prescription (gross)

Summed across the 3 of 8 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1791371

20 ML levocarnitine 200 MG/ML Injection

2,639 Medicaid prescriptions (Q1–Q4 2025) 2% of Levocarnitine prescriptions shown $231,458 gross reimbursement (before rebates) ≈ $88 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2673428

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Levocarnitine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 13 of 32 listed Levocarnitine NDCs with Medicaid activity.

Compare Levocarnitine products

A representative set of FDA-listed product records for Levocarnitine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 45 of 45 products — FDA National Drug Code Directory. See every product, package size and price: browse all 45 Levocarnitine NDCs →

Levocarnitine recall history

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list one Levocarnitine recall since July 2021. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class III Apr 16, 2026 · American Regent, Inc.
Labeling: Missing Label
  • Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01 Lots: Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027 FDA record D-0494-2026 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Levocarnitine RxCUI 42955 4 dose forms · 9 strengths
  2. Dose form (SCDF) Oral Capsule RxCUI 372581 No current FDA listing
    Clinical drug / strength (SCD) 250 MG RxCUI 198561 400 MG RxCUI 848934 500 MG RxCUI 253059
  3. Dose form (SCDF) Oral Solution RxCUI 372583 In current FDA listings
    Clinical drug / strength (SCD) 100 MG/ML RxCUI 315134 300 MG/ML RxCUI 142125
  4. Dose form (SCDF) Oral Tablet RxCUI 372584 In current FDA listings
    Clinical drug / strength (SCD) 330 MG RxCUI 197448 500 MG RxCUI 315135

Look up RxCUI 42955 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Levocarnitine brand names

Levocarnitine is sold under 2 brand names in the FDA directory — Carnitor, Carnitor SF. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Carnitor Carnitor SF

Who makes Levocarnitine: manufacturers and labelers

24 companies list Levocarnitine products with the FDA. By number of product records, the largest are Leadiant Biosciences, Inc., American Regent, Inc., ANI Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Leadiant Biosciences, Inc. 11 American Regent, Inc. 4 ANI Pharmaceuticals, Inc. 4 Rising Pharma Holdings, Inc. 3 Akorn 2 Willow Birch Pharma, LLC 2 Trupharma, Llc 2 Zhejiang Bamboo Pharmaceuticals Co.,Ltd 1 Willow Birch Pharma, LLC. 1 Spectrum Laboratory Products, Inc. 1 Sionc Pharmaceuticals Pvt Ltd 1 Saptalis Pharmaceuticals, LLC 1 Rising Pharmaceuticals, Inc. 1 Professional Compounding Centers of America dba PCCA 1 Professional Compounding Centers of America 1 Nuray Chemicals Private Limited 1 Novitium Pharma LLC 1 Metrochem Api Private Limited 1 Hikma Pharmaceuticals USA Inc. 1 Devatis Inc. 1 Chengda Pharmaceuticals Co. Ltd 1 Biosint S.p.A. 1 Baxter Healthcare Corporation 1 AX Pharmaceutical Corp 1

Levocarnitine drug class (RxNorm)

Levocarnitine belongs to the Carnitine Analog class.

Pharmacologic class Carnitine Analog
Drug family (ATC) Amino acids and derivatives

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

Sources for this Levocarnitine page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Oct 30, 2024
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Levocarnitine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Levocarnitine after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
11
NDC products indexed
45
Distinct labelers/manufacturers represented
24
Linked representative label ⓘ
Leadiant Biosciences, Inc.
Linked label effective
Oct 30, 2024
Composite sections available
17
Linked SPL Set ID
d2133bc3-9c15-48bd-8b16-b8995a6a14cd
Linked SPL Document ID
24e9abdb-6e9d-4f27-9e0f-8e8a3a462615
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Leadiant Biosciences, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →